Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (461-470 of 794) with videos related to

Pageof 80
Sort By:
Scientific Reports|March 9, 2023
Determining the most accurate 16S rRNA hypervariable region for taxonomic identification from respiratory samplesRuben López-Aladid, Laia Fernández-Barat, Victoria Alcaraz-Serrano, et al.
Respiratory Medicine|April 19, 2015
Concept for a study design in patients with severe community-acquired pneumonia: A randomised controlled trial with a novel IGM-enriched immunoglobulin preparation - The CIGMA studyTobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Journal of Intensive Care|March 6, 2021
Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational studyRicard Mellado-Artigas, Luis Eduardo Mujica, Magda Liliana Ruiz, et al.
Critical Care Medicine|December 25, 2012
An in vitro study to assess determinant features associated with fluid sealing in the design of endotracheal tube cuffs and exerted tracheal pressuresGianluigi Li Bassi, Otavio Tavares Ranzani, Joan Daniel Marti, et al.
Eclinicalmedicine|December 18, 2023
Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trialGernot Rohde, Stephan Stenglein, Hans Prozesky, et al.
Archives of Internal Medicine|September 16, 2009
Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study resultsForest W Arnold, A Scott LaJoie, Guy N Brock, et al.
Journal of Clinical Medicine|August 23, 2020
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of <i>Pseudomonas aeruginosa</i>Rosario Menéndez, Raúl Méndez, Isabel Amara-Elori, et al.
Journal of Critical Care|July 28, 2020
Association between sepsis at ICU admission and mortality in patients with ICU-acquired pneumonia: An infectious second-hit modelMariano Esperatti, Nora Fuentes, Miquel Ferrer, et al.
Respiratory Medicine|September 24, 2014
Severity and outcomes of community acquired pneumonia in asthmatic patientsSilvia Terraneo, Eva Polverino, Catia Cilloniz, et al.
Intensive Care Medicine|August 3, 2013
Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective studyMarta Di Pasquale, Mariano Esperatti, Ernesto Crisafulli, et al.
Pageof 80

Showing results (461-470 of 794) with videos related to

Sort By:
Pageof 80
Scientific Reports|March 9, 2023
Determining the most accurate 16S rRNA hypervariable region for taxonomic identification from respiratory samplesRuben López-Aladid, Laia Fernández-Barat, Victoria Alcaraz-Serrano, et al.
Respiratory Medicine|April 19, 2015
Concept for a study design in patients with severe community-acquired pneumonia: A randomised controlled trial with a novel IGM-enriched immunoglobulin preparation - The CIGMA studyTobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Journal of Intensive Care|March 6, 2021
Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational studyRicard Mellado-Artigas, Luis Eduardo Mujica, Magda Liliana Ruiz, et al.
Critical Care Medicine|December 25, 2012
An in vitro study to assess determinant features associated with fluid sealing in the design of endotracheal tube cuffs and exerted tracheal pressuresGianluigi Li Bassi, Otavio Tavares Ranzani, Joan Daniel Marti, et al.
Eclinicalmedicine|December 18, 2023
Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trialGernot Rohde, Stephan Stenglein, Hans Prozesky, et al.
Archives of Internal Medicine|September 16, 2009
Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study resultsForest W Arnold, A Scott LaJoie, Guy N Brock, et al.
Journal of Clinical Medicine|August 23, 2020
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of <i>Pseudomonas aeruginosa</i>Rosario Menéndez, Raúl Méndez, Isabel Amara-Elori, et al.
Journal of Critical Care|July 28, 2020
Association between sepsis at ICU admission and mortality in patients with ICU-acquired pneumonia: An infectious second-hit modelMariano Esperatti, Nora Fuentes, Miquel Ferrer, et al.
Respiratory Medicine|September 24, 2014
Severity and outcomes of community acquired pneumonia in asthmatic patientsSilvia Terraneo, Eva Polverino, Catia Cilloniz, et al.
Intensive Care Medicine|August 3, 2013
Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective studyMarta Di Pasquale, Mariano Esperatti, Ernesto Crisafulli, et al.
Pageof 80